Posted 08 February, 2024
Kyverna Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:KYTX in a 424B4 filed on 08 February, 2024.
This is an initial public offering of shares of common stock of Kyverna Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Kyverna Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.Market Cap
$115M
View Company Details
$115M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.